enGene Therapeutics Inc.
detalimogene
Countdown
908days
Approval decision · ~ Dec 31, 2028 estimated
What's at stake
A final FDA approval decision on detalimogene for its lead indication is expected ~ Dec 31, 2028.
Primary source
· SEC 8-K
verified 13h ago
“regulatory approval from the FDA with respect to detalimogene, provided that such regulatory approval is received by the Company from the FDA no later than December 31, 2028”